Evaluation of Bone Mineral Density in Perimenopausal Period

نویسندگان

  • Ali Etemad Rezaie Rosalind Franklin University of Medicine and Science, North Chicago,USA
  • Farnaz Etemadrezaee Internal Medicine Department, Imam Reza hospital, Mashhad University of Medical Sciences, Mashhad, Iran
  • Hamid Etemad Rezaie Neurosurgery Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
  • Nasrin Milani Internal Medicine Department, Imam Reza hospital, Mashhad University of Medical Sciences, Mashhad, Iran
  • Zhaleh Shariati-Sarabi Internal Medicine Department, Imam Reza hospital, Mashhad University of Medical Sciences, Mashhad, Iran Rheumatic Diseases Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
چکیده مقاله:

Background: The menopausal transition called perimenopause, happens after the reproductive years, and isspecified with irregular menstrual cycles, perimenopause symptoms and hormonal changes. Women going throughperi menopausal period are vulnerable to bone loss.Osteoporosis is one of the most common debilitating metabolic bone diseases ,especially in the women almostaround 50 years .This study was intended to evaluate the prevalence of osteopenia/osteoporosis amongstasymptomatic individuals during the menopause transition period.Methods: A total of 714 asymptomatic peri-menopausal female volunteers were recruited through a billboard invitationfor participation in the study. The subjects were selected based on already defined inclusion and exclusion criteria.The project, which was conducted between 2010 and 2014 was affiliated to the Educational and Therapeutic Center,Imam Reza Hospital, Mashhad, Iran. Bone Mineral Densitometry (BMD) measured by DEXA (dual-energy X-rayabsorptiometry) was carried out on two distinct sites, the proximal femur and the lumbar vertebrae from L1 to L4.Pertained data were analyzed.Results: The mean age of the subjects was 49.7±2.years. The overall prevalence of osteopenia and osteoporosisin these peri-menopausal individuals were 37.6 % and 10% respectively. Thirty five point two percent of 714 womenpresented with osteopenia and eight percent of them have osteoporosis in the femoral neck, respectively. Nonetheless,BMD values at the lumbar spine indicated 41.6% and 12% of individual participants being affected by osteopenia andosteoporosis.Conclusion: In general osteopenia or osteoporosis, occurred in 48% of this study population, implying that specialattention is required for the bone health status of Iranian women who undergo menopause.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

evaluation of sadr eminence in safavid period

چکیده: یکی از دوره های مهم تاریخی ایران به لحاظ تأمین استقلال ملی مذهبی و حتی تأثیر آن بر فرهنگ و مذهب ایرانیان، دوره صفویه است. رسمیت دادن و رواج مذهب شیعه توسط شاه اسماعیل اول، یکی از مهمترین اقدامات این دولت محسوب می شود. بنابراین برای اجرای این سیاست، وی منصب صدارت را به عنوان منصبی مذهبی- حکو متی ایجاد کرد .این منصب از دوره ی تیموریان ایجاد شده بود ولی در اواخر این دوره اهمیت بیشتری یافت...

15 صفحه اول

Evaluation of Antioxidants in Bone Mineral Density of Iranian Osteoporotic Women

Objective(s) Bone is a dynamic tissue that is continuously renewed throughout life by the process of bone remodeling. Antioxidant system might be involved in the pathogenesis of bone loss, so the aim of this study was to evaluate the total antioxidant capacity (TAC), vitamin C and vitamin E levels of plasma besides measuring enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT) an...

متن کامل

Evaluation of bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia

Background: The purpose of this study was to evaluate long-term changes in bone density profile among survivors of childhood acute lymphoblastic leukemia. Patients and Methods: This was a 5 year prospective study comprised of thirty-one survivors of childhood acute lymphoblastic leukemia with a mean age of 11.8 (4.6) years, who completed therapy at least 1 year previously (according to the ...

متن کامل

Changes in bone mineral density and metabolism in women: evaluation of bodily characteristics, bone metabolic markers and bone mineral density.

The relationship of bone mineral density (BMD) and bone metabolic markers in women is an interesting field of research. In this study, we aimed to clarify the relationship of body weight, bone metabolic markers and BMD. The subjects were 72 women. The levels of serum bone-specific alkaline phosphatase (BAP), serum type I collagen-cross-linked peptide (s-NTx) and urinary deoxypyridinoline (u-DPD...

متن کامل

Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study.

OBJECTIVES Although periarticular osteoporosis is a well-recognised phenomenon in rheumatoid arthritis (RA), there is considerable controversy over whether RA is associated with more generalised osteoporosis. The aetiology of this bone loss is probably multifactorial, including both life-style risk factors and disease-related determinants. Population-based studies on bone mineral density (BMD) ...

متن کامل

Serum ferritin levels and bone mineral density in the elderly

Background: Iron overload influences negatively on bone mineral density (BMD) but the results of studies regarding serum ferritin (SF) and BMD are conflicting.This study aimed to determine the association of SF and BMD in the elderly. Methods: All participants of the Amirkola cohort selected between 2011-2012, aged > 60 years were classified as high or normal (<200ng/ml) SF. BMD at femoral nec...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ذخیره در منابع من قبلا به منابع من ذحیره شده

{@ msg_add @}


عنوان ژورنال

دوره 6  شماره 1

صفحات  57- 62

تاریخ انتشار 2018-01-01

با دنبال کردن یک ژورنال هنگامی که شماره جدید این ژورنال منتشر می شود به شما از طریق ایمیل اطلاع داده می شود.

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023